Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

This Week in JAMA

This Week in JAMA Aspirin and Age-Related Macular Degeneration Klein and colleagues examined the relationship between aspirin use and age-related macular degeneration (AMD) in a longitudinal, population-based study that enrolled 4926 individuals aged 43 to 86 years. At clinical eye examinations—performed every 5 years over a 20-year period—study participants were asked whether they had regularly used aspirin at least twice a week for more than 3 months. The authors found that regular aspirin use 10 years prior was associated with a small but statistically significant increase in the risk of incident late and neovascular AMD. SEE Article World Trade Center Exposure and Cancer Risk There has been concern that potentially toxic materials and emissions at the World Trade Center (WTC) site may be associated with cancer risk in exposed individuals. In an analysis of data from the WTC Health Registry—including 21 850 rescue/recovery workers and 33 928 individuals not involved in WTC rescue/recovery operations—and 11 state cancer registries, Li and colleagues found that compared with New York State residents overall, WTC rescue/recovery workers were at excess risk of prostate cancer, thyroid cancer, and myeloma. Risk was unrelated to the intensity of WTC exposure. Video Diabetes Remission After Weight Loss Intervention In an exploratory analysis of data from 4503 participants in the Look AHEAD study—a randomized controlled trial investigating the effect of an intensive lifestyle-based weight loss intervention vs diabetes education and support on cardiovascular disease incidence in adults with type 2 diabetes—Gregg and colleagues examined the association of the lifestyle intervention with remission to prediabetes or normoglycemia. The authors report the lifestyle intervention was associated with a greater likelihood of remission of type 2 diabetes; however, the absolute remission rates were modest and complete remission was rare. In an editorial, Arterburn and O’Connor discuss the future of diabetes prevention and treatment. SEE ArticleArticle PCSK9 Antibody in Statin-Intolerant Patients In a 12-week randomized trial that enrolled 160 adult patients with hypercholesterolemia and statin intolerance due to adverse muscle-related effects, Sullivan and colleagues found that a subcutaneously administered human monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9)—a plasma proprotein that mediates binding and trafficking of low-density lipoprotein (LDL) cholesterol receptors—significantly reduced LDL cholesterol levels. SEE Article CLINICIAN'S CORNERClopidogrel Pretreatment in Patients Undergoing PCI Pretreatment with clopidogrel is recommended for patients with acute coronary syndromes or stable coronary artery disease who are scheduled for percutaneous coronary intervention (PCI); however, effects of clopidogrel pretreatment on important clinical outcomes are not clear. In a systematic review and meta-analysis of data from 15 studies (37 814 patients), Bellemain-Appaix and colleagues found that compared with no pretreatment, receipt of clopidogrel was not associated with a lower risk of mortality or major bleeding but was associated with a reduction in major adverse cardiac events. SEE Article AND AUTHOR AUDIO INTERVIEW Medical News & Perspectives Psychoactive designer street drugs known as “bath salts” may have potentially dangerous and long-lasting adverse effects, and their varied composition can confound clinicians. SEE Article Viewpoints Fungal meningitis: a compounding problem SEE Article Iodine supplementation during pregnancy and lactation SEE Article Making health care reform work SEE Article A Piece of My Mind "We [physicians] tend to imagine ourselves a class apart where health is concerned, and might drift to extremes in our own care, caring either too much or too little." From "A Pain in the Tuches." SEE Article Editor's Audio Summary Dr Bauchner summarizes and comments on this week's issue. Go to http://jama.ama-assn.org/misc/audiocommentary.dtl Author in the Room Teleconference Join Robert H. Shmerling, MD, January 16 from 2 to 3 PM eastern time to discuss management of gout. To register, go to http://www.ihi.org/AuthorintheRoom. JAMA Patient Page For your patients: Information about venous embolism during air travel. SEE Article http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

This Week in JAMA

JAMA , Volume 308 (23) – Dec 19, 2012
Download PDF
1 page

This Week in JAMA

Abstract

Aspirin and Age-Related Macular Degeneration Klein and colleagues examined the relationship between aspirin use and age-related macular degeneration (AMD) in a longitudinal, population-based study that enrolled 4926 individuals aged 43 to 86 years. At clinical eye examinations—performed every 5 years over a 20-year period—study participants were asked whether they had regularly used aspirin at least twice a week for more than 3 months. The authors found that regular aspirin use 10...
Loading next page...
 
/lp/american-medical-association/this-week-in-jama-fan90Y3pOz

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 2012 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2012.3393
Publisher site
See Article on Publisher Site

Abstract

Aspirin and Age-Related Macular Degeneration Klein and colleagues examined the relationship between aspirin use and age-related macular degeneration (AMD) in a longitudinal, population-based study that enrolled 4926 individuals aged 43 to 86 years. At clinical eye examinations—performed every 5 years over a 20-year period—study participants were asked whether they had regularly used aspirin at least twice a week for more than 3 months. The authors found that regular aspirin use 10 years prior was associated with a small but statistically significant increase in the risk of incident late and neovascular AMD. SEE Article World Trade Center Exposure and Cancer Risk There has been concern that potentially toxic materials and emissions at the World Trade Center (WTC) site may be associated with cancer risk in exposed individuals. In an analysis of data from the WTC Health Registry—including 21 850 rescue/recovery workers and 33 928 individuals not involved in WTC rescue/recovery operations—and 11 state cancer registries, Li and colleagues found that compared with New York State residents overall, WTC rescue/recovery workers were at excess risk of prostate cancer, thyroid cancer, and myeloma. Risk was unrelated to the intensity of WTC exposure. Video Diabetes Remission After Weight Loss Intervention In an exploratory analysis of data from 4503 participants in the Look AHEAD study—a randomized controlled trial investigating the effect of an intensive lifestyle-based weight loss intervention vs diabetes education and support on cardiovascular disease incidence in adults with type 2 diabetes—Gregg and colleagues examined the association of the lifestyle intervention with remission to prediabetes or normoglycemia. The authors report the lifestyle intervention was associated with a greater likelihood of remission of type 2 diabetes; however, the absolute remission rates were modest and complete remission was rare. In an editorial, Arterburn and O’Connor discuss the future of diabetes prevention and treatment. SEE ArticleArticle PCSK9 Antibody in Statin-Intolerant Patients In a 12-week randomized trial that enrolled 160 adult patients with hypercholesterolemia and statin intolerance due to adverse muscle-related effects, Sullivan and colleagues found that a subcutaneously administered human monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9)—a plasma proprotein that mediates binding and trafficking of low-density lipoprotein (LDL) cholesterol receptors—significantly reduced LDL cholesterol levels. SEE Article CLINICIAN'S CORNERClopidogrel Pretreatment in Patients Undergoing PCI Pretreatment with clopidogrel is recommended for patients with acute coronary syndromes or stable coronary artery disease who are scheduled for percutaneous coronary intervention (PCI); however, effects of clopidogrel pretreatment on important clinical outcomes are not clear. In a systematic review and meta-analysis of data from 15 studies (37 814 patients), Bellemain-Appaix and colleagues found that compared with no pretreatment, receipt of clopidogrel was not associated with a lower risk of mortality or major bleeding but was associated with a reduction in major adverse cardiac events. SEE Article AND AUTHOR AUDIO INTERVIEW Medical News & Perspectives Psychoactive designer street drugs known as “bath salts” may have potentially dangerous and long-lasting adverse effects, and their varied composition can confound clinicians. SEE Article Viewpoints Fungal meningitis: a compounding problem SEE Article Iodine supplementation during pregnancy and lactation SEE Article Making health care reform work SEE Article A Piece of My Mind "We [physicians] tend to imagine ourselves a class apart where health is concerned, and might drift to extremes in our own care, caring either too much or too little." From "A Pain in the Tuches." SEE Article Editor's Audio Summary Dr Bauchner summarizes and comments on this week's issue. Go to http://jama.ama-assn.org/misc/audiocommentary.dtl Author in the Room Teleconference Join Robert H. Shmerling, MD, January 16 from 2 to 3 PM eastern time to discuss management of gout. To register, go to http://www.ihi.org/AuthorintheRoom. JAMA Patient Page For your patients: Information about venous embolism during air travel. SEE Article

Journal

JAMA – American Medical Association

Published: Dec 19, 2012

There are no references for this article.